Scores | T1: baseline | T2: after surgery | T3: 3 months | T4: six months | ||||
---|---|---|---|---|---|---|---|---|
First axis | Second axis | First axis | Second axis | First axis | Second axis | First axis | Second axis | |
QLQ-C30 (N = 192) | ||||||||
GHS | -0.74 | 0.17 | -0.72 | -0.06 | -0.79 | -0.09 | -0.79 | 0.03 |
Physical functioning | -0.76 | -0.33 | -0.76 | 0.01 | -0.79 | 0.11 | -0.81 | 0.03 |
Role functioning | -0.85 | -0.22 | -0.81 | -0.05 | -0.85 | -0.05 | -0.87 | 0.01 |
Emotional functioning | -0.46 | 0.71 | -0.56 | 0.33 | -0.68 | 0.31 | 0.73 | 0.23 |
Cognitive functioning | -0.57 | 0.34 | -0.69 | 0.01 | -0.67 | 0.34 | -0.70 | 0.23 |
Social functioning | -0.71 | -0.01 | -0.70 | 0.13 | -0.79 | -0.01 | -0.86 | 0.06 |
Fatigue | 0.84 | 0.03 | 0.85 | -0.01 | 0.90 | 0.02 | 0.87 | 0.02 |
Nausea and vomiting | 0.63 | 0.01 | 0.56 | 0.18 | 0.46 | 0.70 | 0.40 | 0.69 |
Pain | 0.77 | 0.19 | 0.81 | 0.07 | 0.69 | -0.33 | 0.75 | -0.02 |
Dyspnea | 0.66 | 0.35 | 0.55 | 0.22 | 0.62 | -0.14 | 0.67 | -0.09 |
Insomnia | 0.41 | -0.63 | 0.54 | -0.38 | 0.63 | -0.15 | 0.63 | -0.23 |
Appetite loss | 0.51 | -0.43 | 0.65 | -0.11 | 0.61 | 0.46 | 0.48 | 0.66 |
Constipation | 0.36 | 0.12 | 0.25 | -0.42 | 0.44 | 0.37 | 0.42 | 0.25 |
Diarrhea | 0.24 | 0.13 | 0.17 | 0.66 | 0.32 | 0.27 | 0.32 | 0.04 |
Financial difficulties | 0.40 | 0.49 | 0.31 | 0.64 | 0.44 | -0.11 | 0.38 | -0.16 |
QLQ-BR23 (N = 154) | ||||||||
Body image | -0.70 | 0.47 | -0.64 | 0.45 | -0.79 | 0.07 | -0.79 | 0.25 |
Sexual functioning | 0.30 | -0.44 | 0.24 | -0.52 | 0.31 | -0.51 | 0.41 | -0.41 |
Future perspective | -0.31 | 0.46 | -0.53 | 0.52 | -0.76 | 0.25 | -0.73 | 0.30 |
Systemic therapy side effects | 0.78 | -0.01 | 0.72 | 0.28 | 0.61 | -0.49 | 0.67 | -0.21 |
Breast symptoms | 0.58 | 0.49 | 0.64 | 0.38 | 0.56 | 0.66 | 0.57 | 0.64 |
Arm symptoms | 0.66 | 0.49 | 0.75 | 0.32 | 0.69 | 0.44 | 0.63 | 0.57 |